Intrinsic Differences Between Authentic and Cryptic 5' Splice Sites

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2003 Oct 25

PMID 14576320

Citations 71

Authors

Xavier Roca

Ravi Sachidanandam

Adrian R Krainer

Affiliations

Soon will be listed here.

Abstract

Cryptic splice sites are used only when use of a natural splice site is disrupted by mutation. To determine the features that distinguish authentic from cryptic 5' splice sites (5'ss), we systematically analyzed a set of 76 cryptic 5'ss derived from 46 human genes. These cryptic 5'ss have a similar frequency distribution in exons and introns, and are usually located close to the authentic 5'ss. Statistical analysis of the strengths of the 5'ss using the Shapiro and Senapathy matrix revealed that authentic 5'ss have significantly higher score values than cryptic 5'ss, which in turn have higher values than the mutant ones. beta-Globin provides an interesting exception to this rule, so we chose it for detailed experimental analysis in vitro. We found that the sequences of the beta-globin authentic and cryptic 5'ss, but not their surrounding context, determine the correct 5'ss choice, although their respective scores do not reflect this functional difference. Our analysis provides a statistical basis to explain the competitive advantage of authentic over cryptic 5'ss in most cases, and should facilitate the development of tools to reliably predict the effect of disease-associated 5'ss-disrupting mutations at the mRNA level.

Citing Articles

Splicing accuracy varies across human introns, tissues, age and disease.

Garcia-Ruiz S, Zhang D, Gustavsson E, Rocamora-Perez G, Grant-Peters M, Fairbrother-Browne A Nat Commun. 2025; 16(1):1068.

PMID: 39870615 PMC: 11772838. DOI: 10.1038/s41467-024-55607-x.

Progerin mRNA expression in non-HGPS patients is correlated with widespread shifts in transcript isoforms.

Yu R, Xue H, Lin W, Collins F, Mount S, Cao K NAR Genom Bioinform. 2024; 6(3):lqae115.

PMID: 39211333 PMC: 11358823. DOI: 10.1093/nargab/lqae115.

U-rich elements drive pervasive cryptic splicing in 3' UTR massively parallel reporter assays.

Dao K, Jungers C, Djuranovic S, Mustoe A bioRxiv. 2024; .

PMID: 39149310 PMC: 11326173. DOI: 10.1101/2024.08.05.606557.

Pleiotropic brain function of whirlin identified by a novel mutation.

Aguilar C, Williams D, Kurapati R, Bains R, Mburu P, Parker A iScience. 2024; 27(7):110170.

PMID: 38974964 PMC: 11225360. DOI: 10.1016/j.isci.2024.110170.

Tumor Antigens beyond the Human Exome.

Emilius L, Bremm F, Binder A, Schaft N, Dorrie J Int J Mol Sci. 2024; 25(9).

PMID: 38731892 PMC: 11083240. DOI: 10.3390/ijms25094673.

References

Hunter T, Melancon S, DALLAIRE L, Taft S, Skopek T, Albertini R . Germinal HPRT splice donor site mutation results in multiple RNA splicing products in T-lymphocyte cultures. Somat Cell Mol Genet. 1996; 22(2):145-50. DOI: 10.1007/BF02369904. View

Teraoka S, Telatar M, Liang T, Onengut S, Tolun A, Chessa L . Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet. 1999; 64(6):1617-31. PMC: 1377904. DOI: 10.1086/302418. View

Bunge S, Steglich C, Zuther C, Beck M, Morris C, Schwinger E . Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet. 1993; 2(11):1871-5. DOI: 10.1093/hmg/2.11.1871. View

Berget S . Exon recognition in vertebrate splicing. J Biol Chem. 1995; 270(6):2411-4. DOI: 10.1074/jbc.270.6.2411. View

Mayeda A, Krainer A . Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell. 1992; 68(2):365-75. DOI: 10.1016/0092-8674(92)90477-t. View

Ris-Stalpers C, Kuiper G, Faber P, Schweikert H, van Rooij H, Zegers N . Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity. Proc Natl Acad Sci U S A. 1990; 87(20):7866-70. PMC: 54851. DOI: 10.1073/pnas.87.20.7866. View

Crispino J, Blencowe B, Sharp P . Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science. 1994; 265(5180):1866-9. DOI: 10.1126/science.8091213. View

Colgin L, Hackmann A, Monnat Jr R . Different somatic and germline HPRT1 mutations promote use of a common, cryptic intron 1 splice site. Mutation in brief no. 259. Online. Hum Mutat. 1999; 14(1):92. DOI: 10.1002/(SICI)1098-1004(1999)14:1<92::AID-HUMU24>3.0.CO;2-#. View

Van Bakel I, Sepp T, Ward S, Yates J, Green A . Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT). Hum Mol Genet. 1997; 6(9):1409-14. DOI: 10.1093/hmg/6.9.1409. View

10.

Wang Q, Forlino A, Marini J . Alternative splicing in COL1A1 mRNA leads to a partial null allele and two In-frame forms with structural defects in non-lethal osteogenesis imperfecta. J Biol Chem. 1996; 271(45):28617-23. DOI: 10.1074/jbc.271.45.28617. View

11.

Sun H, Chasin L . Multiple splicing defects in an intronic false exon. Mol Cell Biol. 2000; 20(17):6414-25. PMC: 86117. DOI: 10.1128/MCB.20.17.6414-6425.2000. View

12.

Eperon I, Ireland D, Smith R, Mayeda A, Krainer A . Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF. EMBO J. 1993; 12(9):3607-17. PMC: 413636. DOI: 10.1002/j.1460-2075.1993.tb06034.x. View

13.

Siliciano P, Guthrie C . 5' splice site selection in yeast: genetic alterations in base-pairing with U1 reveal additional requirements. Genes Dev. 1988; 2(10):1258-67. DOI: 10.1101/gad.2.10.1258. View

14.

Caceres J, Stamm S, Helfman D, Krainer A . Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science. 1994; 265(5179):1706-9. DOI: 10.1126/science.8085156. View

15.

Mayeda A, Krainer A . Mammalian in vitro splicing assays. Methods Mol Biol. 1999; 118:315-21. DOI: 10.1385/1-59259-676-2:315. View

16.

Schwarze U, Starman B, Byers P . Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. Am J Hum Genet. 1999; 65(2):336-44. PMC: 1377932. DOI: 10.1086/302512. View

17.

Dry K, Manson F, Lennon A, Bergen A, van Dorp D, Wright A . Identification of a 5' splice site mutation in the RPGR gene in a family with X-linked retinitis pigmentosa (RP3). Hum Mutat. 1999; 13(2):141-5. DOI: 10.1002/(SICI)1098-1004(1999)13:2<141::AID-HUMU6>3.0.CO;2-Q. View

18.

Jacoby L, Maccollin M, Barone R, Ramesh V, Gusella J . Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer. 1996; 17(1):45-55. DOI: 10.1002/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2. View

19.

Scholl T, Pyne M, Russo D, Ward B . BRCA1 IVS16+6T-->C is a deleterious mutation that creates an aberrant transcript by activating a cryptic splice donor site. Am J Med Genet. 1999; 85(2):113-6. View

20.

Du H, Rosbash M . Yeast U1 snRNP-pre-mRNA complex formation without U1snRNA-pre-mRNA base pairing. RNA. 2001; 7(1):133-42. PMC: 1370063. DOI: 10.1017/s1355838201001844. View